Literature DB >> 16001666

Long-term survival following resection of peritoneal implantation from hepatocellular carcinoma: a case report.

Hong-Shiue Chou1, Kam-Fei Lee, Chun-Nan Yeh, Miin-Fu Chen, Long-Bin Jeng.   

Abstract

This study presents a rare case of long-term survival following the resection of peritoneal implantation from hepatocellular carcinoma (HCC). A 33-year-old female patient with hepatitis B infection presented with a huge pedunculated HCC and underwent left lateral segmentectomy in 1995. She received regular follow-up and peritoneal implantation was diagnosed 30 months after hepatic resection using abdominal computed tomography due to elevated alpha-fetoprotein (AFP). Subsequently, the patient received segmental resection of jejunum and a solitary peritoneal implantation from HCC in the mesentery of the jejunum. No peritoneal carcinomatosis, direct invasion of the surrounding tissue, or lymph node involvement existed and the postoperative course was uneventful. Meanwhile, histopathological examination of the resected nodule revealed metastatic hepatocellular carcinoma. With regular follow-up with AFP, abdominal ultrasonography, and or computed tomography, no intrahepatic tumor recurrence or extrahepatic metastasis was observed. The patient survived for 90 months following hepatic resection, and survived disease free for 60 months after resection of peritoneal implantation from HCC.

Entities:  

Mesh:

Year:  2005        PMID: 16001666

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  2 in total

1.  Efficacy of surgical resection in management of isolated extrahepatic metastases of hepatocellular carcinoma.

Authors:  Kun-Ming Chan; Ming-Chin Yu; Ting-Jung Wu; Chen-Fang Lee; Tse-Ching Chen; Wei-Chen Lee; Miin-Fu Chen
Journal:  World J Gastroenterol       Date:  2009-11-21       Impact factor: 5.742

2.  Surgical Treatment of Postoperative Abdominal Metastases of Hepatocellular Carcinoma: 10-Year Experience in a Single Center.

Authors:  Jiong-Ze Fang; Yong Yang; Hong-Da Zhu; Jian-Nan Sun; Hong-Chao Mi; Cai-De Lu
Journal:  Cancer Manag Res       Date:  2021-11-20       Impact factor: 3.989

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.